Ups and downs in pharma industry due to crucial supply chain hiccups

After months of challenges and faults in the global ingredient supply chain, peaks and valleys are the landscape for Vietnamese drug giants in their first-half performance, 

and several factors remain that could damage their operational prospects in the months to come.

1500p17 ups and downs in pharma industry due to crucial supply chain hiccups
Local drugmakers are coping with serious supply chain disruptions due to the pandemic

Hau Giang Pharmaceutical JSC (DHG), the biggest publicly-traded drugmaker in Vietnam, reported a fall in revenues and profits in the first six months of 2020. Total revenue dropped 3.5 per cent on-year and fulfilled 43.5 per cent of the annual target.

In spite of this, DHG’s total pharmaceutical gross output during the period hit VND2.46 trillion ($106.9 million), up 3.4 per cent on-year and meeting 52.6 per cent of the whole-year target.

DHG now boasts Taisho Pharmaceutical Holdings, one of the five biggest pharmaceuticals in Japan, as a major foreign shareholder, with a take of 50.78 per cent.

Some pharma players have announced their 2020 first-half performance results, while others are still to be revealed.

On July 2, Traphaco JSC, the country’s second-largest publicly-traded drugmaker, held a meeting to review the six-month performance and set targets for the second half, amid the serious impacts of COVID-19.

Traphaco is among the few pharmaceutical firms that gained during the January-June span. It made consolidated revenues of VND850 billion ($36.95 million), up 7 per cent on-year, while profits rose 17 per cent on-year to VND85.4 billion ($3.7 million).

Industry insiders attributed the fruitful result to the fact that Traphaco holds 11.53 per cent of the oriental medicine segment, with 76 per cent of its self-production. Meanwhile, major western medicines like Methorphan and other eye drops such as Quimoxi, Oxflaxacin, and Tobramycin continue to bring about good results and positive prospects, driven by increasing demands for respiratory and eye disease drugs in the country.

On a similar path, Imexpharm Pharmaceutical JSC (IMP), Vietnam’s fourth-biggest pharmaceutical firm, is said to have obtained good business performance during the first half thanks to its sufficient reserves of ingredients and sound business strategies.

In contrast, many drugmakers still suffered losses in the period. Vietnam Pharmaceutical Corporation (Vinapharm) even envisions a 10.5 per cent decrease in its pre-tax profits for 2020.

According to FPT Securities, domestic pharmaceutical businesses giants like DHG, Traphaco, IMP, and Domesco Medical Import-Export JSC face some risks in operations which might cause challenges for them to fulfil their 2020 targets.

Traphaco aims to make consolidated revenue of VND2 trillion ($86.95 million) and consolidated after-tax profit of VND180 billion ($7.8 million) this year, up 16 and 9 per cent on-year, respectively. Meanwhile, DHG aims to increase its pre-tax profit by a percentage point. IMP even set 25 and 28 per cent on-year rises in net revenue and pre-tax profit, respectively.

However, Traphaco is facing some investment risks in its operation in terms of management costs, ingredient imports, and liquidity. Specifically, the company is facing a rise in labour costs and selling expenses after opening an additional eight distribution branches in the past two years, which have not brought about good results.

 

In addition, the drugmaker’s reliance on ingredient imports has impacted on its control of quality and the price of pharmaceutical substances. The main ingredients of its key western products like Methorphan, Quimoxi, Tobramycin, and Moxifloxacin, which make up 7.8 per cent of total net revenue, comes from China and India only.

Worse still, Traphaco has low liquidity and a concentrated shareholder structure in which 75 per cent of stakes are owned by three major stakeholders: State Capital Investment Corporation, Magbi Fund Ltd., and Super Delta Pte., Ltd.

At present, Traphaco is upgrading its Hung Yen western factory to EU-GMP standards to increase its possibility of joining tenders of high-end generic drugs in the ethical drugs channel under Circular No.15/2019/TT-BYT dated July 2019 regulating drug tenders at public hospitals.

The upgrading process requires an extra cost of an estimated VND225 billion ($9.78 million) and is expected to be completed in 2022.

Meanwhile, DHG is hitting hard rocks partly due to over-dependence on antibiotics amid the government’s stricter control over their sales in the over-the-counter market. For the time being, this channel is seeing stiffening competition among domestic businesses in terms of prices and product segments.

DHG’s concerns are increasing in policy risks as its PIC/S Malaysia factory has fewer competitive advantages in tenders of high-end Group II categories of pain and fever drugs under the new circular. On the other hand, DHG’s reliance on 90-per-cent ingredient imports is causing a big problem due to price fluctuation. Up till now, the biggest player has yet to find a solution.

Like Traphaco and DHG, Domesco – the third-biggest publicly-traded drugmaker – is among the hardest-hit from the supply chain break.

If the pandemic continues to develop, Domesco and others will see the shortfall becoming more serious, forcing them to find other supply sources outside China and India, thus resulting in a possible reduction in profit margins.

Meanwhile, IMP is facing risk of acquisition. At present, Vinapharm is the biggest shareholder of IMP with 22.8 per cent, while the total stakeholding of IMP leadership is just 3.1 per cent, resulting in an insufficient veto vote of at least 36 per cent, thus increasing the chances of being acquired.

Currently, IMP’s foreign ownership limit is set at 49 per cent, with Balestrand Ltd., KWE Beteiligungen AG, and other overseas investment funds and financial firms holding a total of 48.4 per cent. This firm has yet to attain a strategic foreign partner. VIR

Bich Thuy

Medical equipment, pharmaceutical companies see bright future after Covid-19

Medical equipment, pharmaceutical companies see bright future after Covid-19

Most medical equipment and pharmaceutical companies reported high revenue and profit growth rates in Q1 in comparison with the same period last year.

Gradual but radical changes set to sweep pharmaceutical landscape

Gradual but radical changes set to sweep pharmaceutical landscape

The upcoming implementation of the EU-Vietnam Free Trade Agreement (EVFTA) is expected to transform the competitive landscape of Vietnam’s pharmaceutical and medical industry. 

 
 

Other News

.
Red boards with this phrase appear densely on Hanoi streets
Red boards with this phrase appear densely on Hanoi streets
BUSINESSicon  05/10/2021 

“Shop for rent”, “space for rent”, “house for rent”, … are the phrases that appear most on the streets of Hanoi after two months of social distancing.

Ministry forecasts Vietnam’s GDP growth this year at 3%-3.5%
Ministry forecasts Vietnam’s GDP growth this year at 3%-3.5%
BUSINESSicon  05/10/2021 

The Ministry of Planning and Investment has projected the country’s gross domestic product (GDP) growth in 2021 at 3%-3.5%, down 0.5 percentage points from the rate forecast in September.

Businesses reopen in HCM City, but challenges remain
Businesses reopen in HCM City, but challenges remain
BUSINESSicon  05/10/2021 

After months of social distancing the reopening of the HCM City economy on October 1 has brought cheer to both businesses and the public.

VIETNAM BUSINESS NEWS OCTOBER 5
VIETNAM BUSINESS NEWS OCTOBER 5
BUSINESSicon  05/10/2021 

 Project aims to enhance trade remedy capacity as Vietnam joins new-generation FTAs

Hanoi removes 28 administrative procedures in investment
Hanoi removes 28 administrative procedures in investment
BUSINESSicon  05/10/2021 

Hanoi’s authorities have decided to remove 28 administrative procedures in the field of investment.

VIETNAM BUSINESS NEWS OCTOBER 4
VIETNAM BUSINESS NEWS OCTOBER 4
BUSINESSicon  04/10/2021 

Vietnam develops rural tourism through digital transformation

Construction ministry proposes legal amendment to prevent 'land fever'
Construction ministry proposes legal amendment to prevent 'land fever'
BUSINESSicon  05/10/2021 

Many real estate brokers lack professional knowledge and ethics and do ‘hit and run’ business, causing losses to customers by giving wrong advice or even cornering the market and causing artificial land fever.

Vietnam warned of serious air pollution in motorization period
Vietnam warned of serious air pollution in motorization period
FEATUREicon  05/10/2021 

Vietnam is about to enter the motorization period when the market will boom and the air will become polluted. Policies on restricting the use of old-technology vehicles and encouraging green, clean vehicles are needed.

Focus turns to stamping out hotbeds, greening the economy
Focus turns to stamping out hotbeds, greening the economy
FEATUREicon  05/10/2021 

The acceleration of vaccinations will help restore production and business activities, and expand green production zones and a green workforce for the economy.

Quality workforce – “bottleneck” of support industry firms
Quality workforce – “bottleneck” of support industry firms
BUSINESSicon  04/10/2021 

The shortage of high-quality workforce is a “bottleneck” faced by domestic support industry enterprises, said economists.

As migrant workers leave cities, who will save businesses?
As migrant workers leave cities, who will save businesses?
FEATUREicon  04/10/2021 

Thousands of migrant laborers have returned to their hometowns to avoid the pandemic, leaving behind city dreams. The consequence is that enterprises lack workers to restore production in the "new normal".

Basa fish industry in the Mekong Delta hit hard by social distancing
Basa fish industry in the Mekong Delta hit hard by social distancing
BUSINESSicon  04/10/2021 

As of mid-September, basa harvesting is estimated at 932,000 tonnes, only 81.1 per cent of the same period last year.

Vietnamese manufacturing hit by pandemic
Vietnamese manufacturing hit by pandemic
BUSINESSicon  04/10/2021 

The Vietnam Manufacturing Purchasing Managers' Index (PMI) remained at 40.2 in September.

HCM City businesses propose support policies
HCM City businesses propose support policies
BUSINESSicon  04/10/2021 

Businesses in HCM City have called for support policies to help them revive operations after disruption caused by the COVID-19 pandemic.

Vietnamese ICT businesses benefit from digital consumption
Vietnamese ICT businesses benefit from digital consumption
BUSINESSicon  04/10/2021 

Vietnamese ICT enterprises have benefited greatly from the fast digitalisation trend, with their revenues rising despite the COVID-19 pandemic.

Vietnam’s economy to slow as population ages: WB report
Vietnam’s economy to slow as population ages: WB report
BUSINESSicon  04/10/2021 

Population aging could slow down Vietnam's long-term growth in the 2020–2050 period by 0.9 percentage points compared with the last 15 years, a new World Bank (WB) report finds.

Millions of US dollars poured into green growth projects
Millions of US dollars poured into green growth projects
BUSINESSicon  03/10/2021 

Capital flows into green growth projects have still seen positive signals despite adverse impacts from the COVID-19 pandemic on foreign direct investment (FDI) in Vietnam.

Vietnam likely to attain trade surplus in 2021
Vietnam likely to attain trade surplus in 2021
BUSINESSicon  03/10/2021 

Vietnam is in a favorable condition to take advantage of free trade agreements (FTA) that the country is a part of, as well as growing global demand in the late-year shopping season.

Private sector plays key role in post-pandemic recovery
Private sector plays key role in post-pandemic recovery
FEATUREicon  03/10/2021 

Vietnam's emerging and dynamic private sector proved its resilience during the Covid-19 pandemic as it helped the country become one of the few countries to obtain positive growth in 2020. 

No price hike on power bill until the end of the year: MoIT
No price hike on power bill until the end of the year: MoIT
BUSINESSicon  02/10/2021 

There will be no increase in electricity prices from now until the end of the year, the Ministry of Industry and Trade (MoIT) - the country's power regulator - announced yesterday during the ministry's monthly press conference.

 
 
 
Leave your comment on an article

OR QUICK LOGIN